Injectable Drug Delivery News

  1. WuXi STA Launches Another Parenteral Formulation Manufacturing Line At Wuxi City Site 12/1/2022

    WuXi STA, a subsidiary of WuXi AppTec, today announced a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units.

  2. Recipharm Invests In Its Single Dose Nasal Platform Capabilities 11/30/2022

    Recipharm, a global contract development and manufacturing organisation (CDMO), has announced that it is expanding its capabilities for its proprietary Unidose Xtra (single dose) nasal delivery platform.

  3. Kindeva Drug Delivery And Meridian Medical Technologies To Combine 11/15/2022

    Kindeva Drug Delivery announced that it will combine with Meridian Medical Technologies. The combination will create a leading global drug-device combination product CDMO. Kindeva and Meridian will continue to operate independently until closing.

  4. Bridgewest Group Inks Deal With Pfizer To Acquire Injectable Manufacturing Plant In Western Australia 11/11/2022

    Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, is expanding its portfolio. Today, Bridgewest Group has announced the signing of a definitive agreement to purchase the sterile injectable manufacturing facility of Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc.

  5. CMO Berkshire Sterile Manufacturing To Reveal New Isolator-Based Aseptic Filling Line November 16th 11/9/2022

    Fill Finish CMO, Berkshire Sterile Manufacturing (BSM), will reveal its new, fully automated, 100% isolator-based filling line in a webinar on November 16th at 1PM EST.

  6. Aptar Pharma Announces Collaboration With TFF Pharmaceuticals 11/7/2022

    Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced a collaboration with TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform.

  7. Stevanato Group And Gerresheimer AG Present EZ-Fill Smart, A New And Innovative Ready-To-Use Vial Platform 11/1/2022

    Leveraging the established EZ-fill® market leading technology, process, and product optimization to improve quality, reduce total cost of ownership, and shorten lead times.

  8. Terumo Pharmaceutical Solutions Expands CDMO Services Outside Japan For Global Market 10/31/2022

    Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

  9. Cingulate Announces Agreement With Societal CDMO And Provides Clinical Update 10/24/2022

    Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has executed a Master Services Agreement (MSA) with Societal CDMO, Inc. (NASD: SCTL), a bi-coastal contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development.

  10. INCOG BioPharma Primes Multi-Use Filling Line For Launch 10/19/2022

    INCOG BioPharma Services, a contract development and manufacturing organization (CDMO), specializing in sterile injectables, has achieved another milestone by completing the installation of its state-of-the-art OPTIMA MultiUse production filling line at its Fishers headquarters.